Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Vaccine authorized for emergency use in California condors amid bird flu outbreak

California condors will receive a vaccine for a deadly strain of avian influenza that threatens the already critically endangered vulture species

The Independent UK · May 16, 2023

Vaccine support plummeting among Republicans, Pew survey finds

Americans on the whole have a largely positive view of childhood vaccinations

The Independent UK · May 16, 2023

Should I get a flu vaccine this year? Here's what you need to know

After having low rates of influenza (flu) transmission in recent years thanks to our COVID control strategies, case numbers are now rising.

The Conversation · May 16, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Brazil's Bolsonaro faces questioning in fake vaccine card investigation

Brazil’s former President Jair Bolsonaro is facing questions at the Federal Police headquarters in Brasilia as part of an investigation into alleged falsification of COVID-19 vaccine cards

The Independent UK · May 16, 2023

Chlamydia is killing Australia's koalas, but ambitious new project could stop the spread

A new vaccine could protect the marsupials from the sexually transmitted disease, which can lead to blindness, infertility and death.

LiveScience · May 16, 2023

London children to be offered MMR and polio vaccines through primary schools

Parents urged to check children’s vaccination status amid rise in measles cases

Evening Standard · May 16, 2023

Dengue vaccine: India moves closer to getting its first indigenous vaccine

Moving closer to being able to develop the country’s first vaccine against dengue, drug-makers Serum Institute of India and Panacea Biotec have applied to the Indian Council of Medical Research’s (ICMR) call for Expression of Interest’ for collaborative Phase-III clinical trials for indigenous manufacturers.

The Hindu · May 16, 2023

Read news from The Economist, FT, and more,
with one subscription

These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It

New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.

Inverse · May 15, 2023

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

The Walrus · May 15, 2023

What are the symptoms of RSV and how long is it contagious for? Let's unpack this common cold virus

This respiratory virus is so common that most children will have had at least one infection before they turn two. Most cases are mild, but it can cause severe illness for young children, the elderly and the immunocompromised.

ABC News · May 14, 2023

Little boy, 4, with rare cancer desperately needs £250,000 for American drug trial

Calum Rae’s only chance of survival could be an experimental vaccine costing £250,000, which could help his body to fight off his rare aggressive neuroblastoma cancer

Daily Mirror · May 14, 2023

G7 plans new vaccine effort for developing nations, Yomiuri reports

The Group of Seven (G7) rich nations is set to agree on establishing a new programme to distribute vaccines to developing countries at next week's summit of leaders, Japan's Yomiuri newspaper said on Saturday.

Reuters · May 13, 2023

Coronavirus FAQ: 'Emergency' over! Do we unmask and grin? Or adjust our worries?

Now that official COVID emergency declarations have ended, how should people evaluate their risk of SARS-CoV-2? That's the subject of our frequently asked questions offering.

WEKU · May 12, 2023

Cancer vaccine firm AilseVac becomes QUB's 100th spinout with £1.5M funding

The company identifies and develops therapeutic vaccines which work with the body to overcome cancer

Birmingham Post · May 12, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · May 12, 2023

Obesity speeds up loss of immunity from COVID vaccines – new research

COVID vaccines are very effective, but for some groups they don’t generate as strong an immune response. These groups include older adults and people with weakened immune systems, for example due to cancer or other medical conditions. They tend to already be at heightened risk from COVID.

The Guardian - US · May 11, 2023

US Covid emergency status ends as officials plan ‘new phase of managing’ virus

Vaccines and medication will remain available for free ‘while supplies last’ but most Americans will have to pay for testing

Al Jazeera · May 11, 2023

Three years, 1.1 million deaths: COVID emergency ending in US

As US public health emergency declaration comes to an end, Al Jazeera looks at the pandemic’s heavy toll on the country.

Evening Standard · May 11, 2023

Low uptake of MMR vaccine letting measles ‘gain foothold’ in London

Senior health official warns capital could see further outbreaks if children don’t receive jab

Get all your
news in one place.

100's of premium titles.
One news app.

Bristol Post · May 10, 2023

Bristol has the lowest uptake of MMR vaccines in the South West amid spiking measles cases

There has been a spike in measles cases recently

The New Daily · May 10, 2023

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

Daily Mirror · May 10, 2023

Victorian disease set to make comeback as low vaccine numbers 'begging for outbreak'

Measles is a highly infectious disease that can lead to serious problems such as pneumonia, meningitis, and on rare occasions, long-term disability or death. Symptoms include a high fever, sore red watery eyes and a blotchy red-brown rash.

The Guardian - UK · May 10, 2023

Andrew Bridgen becomes first Reclaim MP after expulsion from Tories

Leicestershire MP was kicked out by Conservatives for comparing Covid vaccines to Holocaust

The Independent UK · May 10, 2023

Former Tory MP sues Matt Hancock over claims his Covid vaccines tweet was ‘antisemitic’

A spokesman for the former health secretary described the North West Leicestershire MP’s legal action as a ‘pathetic publicity stunt’

The Conversation · May 10, 2023

FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The U.S. Food and Drug Administration approved the world’s first vaccine to prevent the respiratory infection RSV, short for respiratory syncytial virus, on May 3, 2023. The new shot represents six decades of starts and stops in the hunt for a vaccine to curb one of the most common winter…

Evening Standard · May 10, 2023

Andrew Bridgen sues Matt Hancock for libel over vaccine tweet row and confirms switch to Reclaim

Former Tory MP Andrew Bridgen announced he is formally suing Matt Hancock for libel on Wednesday in a row over a vaccines tweet.

1 … 167 168 169 170

Coverage From

People

Luiz Inácio Lula da Silva

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Centers for Disease Control and Prevention

574 stories

Oxfam

573 stories

University of Edinburgh

461 stories

Pew

352 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

North West Leicestershire

19 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.